Kelonia Therapeutics logo

Kelonia Therapeutics Employee Directory

Biotechnology ResearchMassachusetts, United States51-200 Employees

Kelonia Therapeutics, based in Boston, Massachusetts, is a biotechnology company focused on developing in vivo gene delivery therapies. Its platform uses a small set of potent vector-like particles to deliver genetic cargo directly to the intended tissue, aiming for precise, tissue-specific expression. The company is building a pipeline of genetic medicines intended to treat solid tumors, hematologic cancers, and other diseases.

In January 2026, the FDA cleared the IND for KLN-1010 for relapsed and refractory multiple myeloma, marking a step toward clinical testing. Recent reporting notes Kelonia is pursuing in vivo CAR-T therapies, including a bispecific program targeting BCMA and CD19, alongside other undisclosed discovery-stage assets.

Find Kelonia Therapeutics employees' phone numbers or email addresses

Kelonia Therapeutics Global Highlights

Location
Employees

North America
74

Minus sign iconPlus sign icon
  • United States Of America
    73
  • Mexico
    1

Europe
2

Minus sign iconPlus sign icon
  • France
    2

Kelonia Therapeutics's Leadership

  • Stylized image of a person
    S. C.
    Vp Clinical Development Operations
    Phone icon
  • Stylized image of a person
    S. G.
    Vice President, Talent & Culture
    Phone icon
  • Stylized image of a person
    S. G.
    Vice President, Preclinical Research
    Phone icon
  • Stylized image of a person
    S. S.
    Vice President, Biotherapeutic Engineering
    Phone icon
  • Stylized image of a person
    S. C.
    Directeur Chez Kelonia
    Phone icon

Kelonia Therapeutics Employee Metrics

100%
50%
0%
2026
2025
  • Research
  • Engineering
  • Operations
  • Administrative
  • Biotechnology
  • Other
  • Program & Project Management
  • Human Resources
  • Business
  • Branding
  • Entrepreneurship
  • Community & Social Services
  • Recruiting

Contact profiles from Kelonia Therapeutics

Name
Title
Contact Info
Location
Last Update
  • Stylized image of a person
    S. G.
    Vice President, Talent & Culture
    Phone icon
    Jun 27, 2026
  • Stylized image of a person
    S. C.
    Vp Clinical Development Operations
    Phone icon
    Jun 25, 2026
  • Stylized image of a person
    S. G.
    Vice President, Preclinical Research
    Phone icon
    Jun 25, 2026
  • Stylized image of a person
    S. S.
    Vice President, Biotherapeutic Engineering
    Phone icon
    Jul 30, 2026
  • Stylized image of a person
    S. C.
    Directeur Chez Kelonia
    Phone icon
    RéunionReunion
    Mar 04, 2024

Frequently Asked Questions

What is Kelonia Therapeutics known for?

Minus sign iconPlus sign icon
Kelonia Therapeutics operates in the Biotechnology Research industry. Explore Kelonia Therapeutics's company overview page for more information.

What is Kelonia Therapeutics's most common email format?

Minus sign iconPlus sign icon
Kelonia Therapeutics employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more Kelonia Therapeutics email formats with LeadIQ.

How many employees does Kelonia Therapeutics have currently?

Minus sign iconPlus sign icon
Kelonia Therapeutics has approximately 74 employees as of July 2026. These team members are located across 2 continents, including North AmericaEurope.

Who are Kelonia Therapeutics's key employees and leadership?

Minus sign iconPlus sign icon

As of July 2026, Kelonia Therapeutics's key employees include:

  • Vp Clinical Development Operations: S. C.
  • Vice President, Talent & Culture: S. G.
  • Vice President, Preclinical Research: S. G.
  • Vice President, Biotherapeutic Engineering: S. S.
  • Directeur Chez Kelonia: S. C.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.